MERGING SUSTAINABLE AND DIGITAL CHEMICAL TECHNOLOGIES FOR THE DEVELOPMENT OF GREENER-BY-DESIGN PHARMACEUTICALS
Safe- and green-by-design are pre-market design approaches whereby the
objectives of minimizing the use of hazardous chemicals, reducing greenhouse
gas emissions, and fostering the reuse and recycling of materials in a
circular economy are built into product design.
SUSPHARMA fits the European need for sustainable development in modern
industry and will develop during the action greener routes to prepare
molecules, such as therapeutics and diagnostics.
The project will thus benefit from an interdisciplinary domain, involving:
- recent advances in biomass conversion for drug synthesis;
- new developments in heterogeneous catalysis;
- cutting-edge flow chemistry technologies (including synthesis
and purification);
- automation and machine learning.
With its action, SUSPHARMA aims to address different societal challenges of
pharmaceutical synthesis, enabling a reduction of the pollution generated
during drug manufacturing.